Llamas for New Ways to Fight the Flu
Researchers are making tremendous strides toward developing better ways to scale back our risk of getting the flu. And one among the newest ideas for foiling the flu—a “gene mist” that would be sprayed into the nose—comes from a most surprising source: llamas. Like humans and lots of other creatures, these fuzzy South American relatives of the camel produce immune molecules, called antibodies, in their blood when exposed to viruses and other foreign substances. Researchers speculated that because the llama’s antibodies are such a lot smaller than human antibodies, they could be easier to use therapeutically in avoiding a good range of flu viruses. this concept is now being leveraged to style a replacement sort of gene therapy which will someday provide humans with broader protection against the flu [1]. Recently, a world team, funded partially by NIH, has begun applying a number of this fundamental knowledge about llama antibodies to our ongoing battle against the flu. of experiments that have opened the door to the likelihood of a replacement flu-fighting “gene mist.” The work began with researchers giving llamas a reasonably traditional flu shot that contained three different influenza viruses and a viral surface protein called hemagglutinin from two other viruses, representing influenza A and B strains.
Those studies revealed the foremost essential portions of the four sorts of antibodies for recognizing influenza viruses, each targeting a special , highly conserved location on the surface hemagglutinin of flu viruses. A conserved location is one that has been maintained through evolution, meaning the antibody’s target are going to be present in most viral strains, instead of changing from year to year. tube studies showed that this quadruple threat effectively targets and neutralizes dozens of influenza A and B viruses, including several sorts of avian influenza, or bird flu. The antibody treatment completely protected the mice against many influenza viruses that otherwise would are deadly. Then, with collaborators at the University of Pennsylvania, Philadelphia, the team tried a special delivery method. noses of mice. The viral vectors then inserted the genes into tract cells, which successively produced the specified four-in-one antibody. every week later, the mice were exposed in aerosol form to varied , potentially lethal influenza viruses—but they were protected. The researchers are hopeful that an identical “gene mist” approach might provide humans with broad protection against multiple influenza strains. However, they acknowledge that such protection would gradually wear off because the cells lining the nasal passages turn over. So, counting on how long that takes, it’s possible that folks would still got to get an annual flu shot. Many questions remain to be answered before this “gene mist” approach to avoiding the flu could be ready for human studies to guage its safety and effectiveness. And there are other intriguing possible advantages. for instance , the rapid protection this approach might afford, along side its potential to neutralize many sorts of avian influenza, suggest it'd be called into action to assist quell an emerging flu pandemic much more swiftly than is feasible with traditional vaccines. Of course, none of this is often reality yet. As we glance to the flu season already underway, the simplest thanks to protect yourself and your loved ones is to urge your annual flu shot. So, if you’ve been procrastinating, don’t wait any longer! References: Wilson IA. Science. 2018 Nov 2;362(6414):598-602. [2] present antibodies barren of light chains.
Those studies revealed the foremost essential portions of the four sorts of antibodies for recognizing influenza viruses, each targeting a special , highly conserved location on the surface hemagglutinin of flu viruses. A conserved location is one that has been maintained through evolution, meaning the antibody’s target are going to be present in most viral strains, instead of changing from year to year. tube studies showed that this quadruple threat effectively targets and neutralizes dozens of influenza A and B viruses, including several sorts of avian influenza, or bird flu. The antibody treatment completely protected the mice against many influenza viruses that otherwise would are deadly. Then, with collaborators at the University of Pennsylvania, Philadelphia, the team tried a special delivery method. noses of mice. The viral vectors then inserted the genes into tract cells, which successively produced the specified four-in-one antibody. every week later, the mice were exposed in aerosol form to varied , potentially lethal influenza viruses—but they were protected. The researchers are hopeful that an identical “gene mist” approach might provide humans with broad protection against multiple influenza strains. However, they acknowledge that such protection would gradually wear off because the cells lining the nasal passages turn over. So, counting on how long that takes, it’s possible that folks would still got to get an annual flu shot. Many questions remain to be answered before this “gene mist” approach to avoiding the flu could be ready for human studies to guage its safety and effectiveness. And there are other intriguing possible advantages. for instance , the rapid protection this approach might afford, along side its potential to neutralize many sorts of avian influenza, suggest it'd be called into action to assist quell an emerging flu pandemic much more swiftly than is feasible with traditional vaccines. Of course, none of this is often reality yet. As we glance to the flu season already underway, the simplest thanks to protect yourself and your loved ones is to urge your annual flu shot. So, if you’ve been procrastinating, don’t wait any longer! References: Wilson IA. Science. 2018 Nov 2;362(6414):598-602. [2] present antibodies barren of light chains.
No comments:
Post a Comment